Drug or technology

Alpelisib

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 2 TRIAL

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

ClinicalTrials.gov

Early-phase, single-centre Phase 2 interventional study with small planned enrollment (n=15) examining a surrogate endpoint (hyperglycemia-free rate) in an exploratory design; results not yet reported in this registry record.

PreliminaryBreast Cancer Stage Iv Metastatic Breast Cancer Alpelisib

Reported

Planned enrollment15

Primary outcome measureHyperglycemia-free rate for participants at…

PhasePhase 2

AUG 7, 2026 · PHASE 2 TRIAL

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ClinicalTrials.gov

This is a Phase 2 screening trial registry record with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.

PreliminaryNCT05564377 Anatomic Stage III Breast Cancer AJCC V8 National Cancer Institute (NCI)

Reported

Planned enrollment2900

Study phasePhase 2

Primary outcome measure timeframeUp to 8 years